Errata (DOI:10.1016/j.juro.2008.06.022);Prostate Cancers Diagnosed at Repeat Biopsy are Smaller and Less Likely to be High Grade

Journal of Urology

Volumn 180, Issue 4, 2008, Pages 1325-1329

  Tan, Nelly ^a   Lane, Brian R ^a   Li, Jianbo ^a   Moussa, Ayman S ^a   Soriano, Meghan ^a   Jones, J Stephen ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

biopsy; prostate; prostate specific antigen; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGE DISTRIBUTION; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; DIAGNOSTIC ACCURACY; DIGITAL RECTAL EXAMINATION; GLEASON SCORE; HUMAN; IMMUNOASSAY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE SPECIFIC ANTIGEN DENSITY; REPEAT PROCEDURE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STRATIFICATION;

EID: 51149102294     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.11.002     Document Type: Erratum

References (20)

1. Carter H.B., Pearson J.D., Metter E.J., Brant L.J., Chan D.W., Andres R., et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267 (1992) 2215
2. Catalona W.J., Partin A.W., Slawin K.M., Brawer M.K., Flanigan R.C., Patel A., et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 279 (1998) 1542
3. Lopez-Corona E., Ohori M., Wheeler T.M., Reuter V.E., Scardino P.T., Kattan M.W., et al. Prostate cancer diagnosed after repeat biopsies have a favorable pathological outcome but similar recurrence rate. J Urol 175 (2006) 923
4. Park S., Shinohara K., Grossfeld G.D., and Carroll P.R. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy. J Urol 165 (2001) 1409
5. Potter S.R., Horniger W., Tinzl M., Bartsch G., and Partin A.W. Age, prostate-specific antigen, and digital rectal examination as determinants of the probability of having prostate cancer. Urology 57 (2001) 1100
6. Epstein J.I., Walsh P.C., Akingba G., and Carter H.B. The significance of prior benign needle biopsies in men subsequently diagnosed with prostate cancer. J Urol 162 (1999) 1649
7. Djavan B., Ravery V., Zlotta A., Dobronski P., Dobrovits M., Fakhari M., et al. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?. J Urol 166 (2001) 1679
8. Epstein J.I., Walsh P.C., Sauvageot J., and Carter H.B. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer. J Urol 158 (1997) 1886
9. Hoffman R.M., Denberg T., Hunt W.C., and Hamilton A.S. Prostate cancer testing following a negative prostate biopsy: over testing the elderly. J Gen Intern Med 22 (2007) 1139
10. Epstein J.I., Allsbrook Jr. W.C., Amin M.B., and Egevad L.L. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29 (2005) 1228
11. Epstein J.I., Walsh P.C., Carmichael M., and Brendler C.B. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 271 (1994) 368
12. Haas G.P., Delongchamps N.B., Jones R.F., Chandan V., Serio A.M., Vickers A.J., et al. Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence. J Natl Cancer Inst 99 (2007) 1484
13. Jones J.S. Saturation biopsy for detecting and characterizing prostate cancer. BJU Int 99 (2007) 1340
14. Jones J.S., Patel A., Schoenfield L., Rabets J.C., Zippe C.D., and Magi-Galluzzi C. Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J Urol 175 (2006) 485
15. Stamey T.A., Caldwell M., McNeal J.E., Nolley R., Hemenez M., and Downs J. The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?. J Urol 172 (2004) 1297
16. Figler B.D., Reuther A.M., Dhar N., Levin H., Magi-Galluzzi C., Zhou M., et al. Preoperative PSA is still predictive of cancer volume and grade in late PSA era. Urology 70 (2007) 711
17. Ochiai A., Troncoso P., and Babaian R.J. The relationship between serum prostate specific antigen level and tumor volume persists in the current era. J Urol 177 (2007) 903
18. Steyerberg E.W., Roobol M.J., Kattan M.W., van derKwast T.H., de Koning H.J., and Schroder F.H. Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram. J Urol 177 (2007) 107
19. Hong Y.M., Lai F.C., Chon C.H., McNeal J.E., and Presti Jr. J.C. Impact of prior biopsy scheme on pathologic features of cancers detected on repeat biopsies. Urol Oncol 22 (2004) 7
20. Sajadi K.P., Terris M.K., Hamilton R.J., Cullen J., Amling C.L., Kane C.J., et al. Body mass index, prostate weight and transrectal ultrasound prostate volume accuracy. J Urol 178 (2007) 990